For example, we found that patients with HER2 + BC and LMD who received any hormone therapy had significantly longer times between their CNS metastases and LMD diagnosis, however, this could be due to endocrine therapy itself or it could be due to the nature of HR + endocrine sensitive disease. This evidence concerns the gene ERBB2 and Langer mesomelic dysplasia.